Valuation
Login to View
Max Portfolio %
Login to View
BPMC RSI Chart
Valuation
Login to View
Max Portfolio %
Login to View
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
How Blueprint Medicines Corp generates revenue and covers its expenses, based on the latest reported earnings.
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | 562.1M | - | - | - |
| 2024 | 282.2M | 362.8M | 434.4M | 508.8M |
| 2023 | 204.6M | 225.6M | 216.2M | 249.4M |
| 2022 | 221.2M | 230.5M | 272.3M | 204.0M |
| 2021 | 640.3M | 486.9M | 333.5M | 180.1M |
| 2020 | 71.9M | 312.5M | 553.1M | 793.7M |
| 2019 | 50.0M | 55.5M | 61.0M | 66.5M |
| 2018 | 27.2M | 33.0M | 38.7M | 44.5M |
| 2017 | 26.8M | 25.6M | 27.5M | 21.4M |
| 2016 | 17.6M | 22.0M | 24.7M | 27.8M |
| 2015 | - | - | - | 11.4M |
| CEO | Ms. Kathryn Haviland |
|---|---|
| WEBSITE | blueprintmedicines.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 660 |